Universal Informatics · Research reading room

A pilot study of the feasibility and preliminary outcomes of sequential TF-CBT and EMDR online group therapy for adult women with histories of childhood sexual abuse.

Milagros Molero-Zafra; María Jesús Hernández-Jiménez; Olga Fernández-García; Marián Pérez-Marín · Frontiers in Psychology · 2026 · Pilot randomized sequence study; completer analysis

Original publication · Original publication · Original publication · Original publication

Recorded summary

Most statistical tests were nonsignificant; descriptive gains among nine completers do not establish efficacy.

Recorded limitations

71% attrition, tiny sequence groups and no long-term follow-up; not independent replication of the 2024 report.

Evidence and provenance

Chapter Trust Factor uses a minimum of three distinct qualifying studies. Publication records retain their own evidence and assessment.

Study design and assessment
design
Pilot randomized sequence study; completer analysis
assessment
category
rct
is Randomized Controlled Trial
true
basis
Full text reports randomized sequence assignment; same family as the 2024 trial.
sources

https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

review Scope
full-text
trust Factor
scope
Paper
status
assessed
score
2
randomized Controlled Trial
true
peer Reviewed
true
blinding
not-confirmed
basis
Full text reports randomized sequence assignment; same family as the 2024 trial.
sources

https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

review Scope
full-text
human Approval
false
display Crosses
2
masking Roles
participants
not established from accessed source
providers
not established from accessed source
assessors
Not blinded
analysts
not established from accessed source
rating Scale
library-trust-factor/1-3
jadad
status
unassessed
score
Not recorded
evidence
evidence Type
Pilot randomized sequence study; completer analysis
intervention
Sequential EMDR G-TEP and TF-CBT Sixteen sessions across two eight-week phases.
comparator
Reverse treatment sequence; no untreated control.
sample
9 of 31 eligible recruits completed both phases (5 EMDR→CBT, 4 CBT→EMDR).
measurement
Feasibility/retention; Symptoms and life satisfaction
timing
end of sixteen-week sequence; end of sequence
trial Id
NCT04813224
relationship Note
Related adult childhood-abuse evidence with explicit family-violence exposure in part of the cohort. Family violence is documented for part of the cohort, but not a whole-sample adult-IPV effect; no ongoing-violence outcome.
measured Genes
None recorded
pathways
None recorded
source Access
level
full-text
source URLs

https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML

retrieved At
2026-10-30T07:22:28.727073+00:00
outcomes
  1. name
    Feasibility/retention
    follow Up
    end of sixteen-week sequence
    result
    Nine of 31 completed the sequential protocol.
    effect Estimate
    29% retention
    uncertainty
    not established from accessed source
    primary Status
    feasibility focus
  2. name
    Symptoms and life satisfaction
    follow Up
    end of sequence
    result
    Descriptive changes; most statistical tests nonsignificant.
    effect Estimate
    not established from accessed source
    uncertainty
    not established from accessed source
    primary Status
    not established from accessed source
quality
risk Of Bias
Exploratory completer-only analysis, high attrition, multiple comparisons.
attrition
9/31 completed both phases: 29% retention.
confounding
not established from accessed source
adverse Findings
No serious adverse events reported; evidence limited to this small retained sample.
transfer Limits
Adult clinical samples do not establish benefit for children or violence prevention.
jadad
not established
masking Roles
participants
not established from accessed source
providers
not established from accessed source
assessors
Not blinded
analysts
not established from accessed source
population
relation
related
population
Adult women with childhood sexual abuse
exposure Evidence
Full-text participant section describes CSA as frequently intrafamilial, with no exact whole-sample proportion; illustrative case involved intrafamilial CSA. Same NCT04813224 family as 2024.
rationale
Related adult childhood-abuse evidence with explicit family-violence exposure in part of the cohort.
transfer Limit
Family violence is documented for part of the cohort, but not a whole-sample adult-IPV effect; no ongoing-violence outcome.
Topics and recorded topic scores
  1. key
    vision:domestic-family-violence
    title
    Domestic & Family Violence
    collection
    vision
    trust Score
    2
Citation snapshot and identifiers
id
dv-vision-42529059
doi
10.3389/fpsyg.2026.1872104
pmid
42529059
citation Snapshot
count
Not recorded
source
Not recorded
retrieved At
Not recorded
status
not-assessed
citations By Collection
vision
Not recorded
Complete approved library record
publication Approval
status
approved-for-publication
approved By
Ben Korbel
approved At
2026-11-01
assessment
AI assessed; human approved for publication
scope
Qualified research-library summaries. No professional clinical peer review or treatment recommendation is claimed.
source Revision
audit-r2-4979b3c28950
source Content Hash
4979b3c28950d0de7d0b768204ad0d88cb284cfc41cba08f3f5c5b2c183caa1c
source Access
level
full-text
source URLs

https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML

retrieved At
2026-10-30T07:22:28.727073+00:00
editorial Audit
auditor
Codex (AI)
completed At
2026-10-31T05:11:05.655793+00:00
prior Content Hash
373a37ef943dc843ef68b101aa8bbbbe93cc399953d50ecb03023bbd3e540359
prior Revision
r1-373a37ef943d
prior Source
frozen-120
source Verification
id
dv-vision-42529059
doi
10.3389/fpsyg.2026.1872104
pmid
42529059
fresh Metadata
Europe PMC core
metadata Retrieved
true
metadata SHA256
f57f9460d8b78aab429595ec73b0c944d01e041599d13bcf4874e6fccf840d63
claim Check
Headline finding/design/limitations compared with indexed abstract or accessible primary evidence; retained methods amendments separately adjudicated.
sources

https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

applied Proposals
None recorded
method
AI editorial assessment of all 130 publication records: compare identity, headline finding, design, relevance and limitations with indexed abstracts or available primary material; adjudicate retained source-supported methods amendments. This is a source-limited publication audit, not an independent full-text systematic review or a clinical guideline.
limitations

Abstract-only records do not establish allocation concealment, complete harms reporting or full risk of bias. · No formal independent RoB 2, GRADE appraisal or numerical reconstruction of every effect was performed. · Source-access labels describe retained appraisal evidence; fuller prior appraisals were checked through their source ledgers and selected material, not independently repeated in full. · Publication counts are not independent trial or participant counts; cohort links and overlapping review evidence remain provisional. · A randomized design cross does not indicate benefit, low risk of bias or human approval. No double-blind trial is verified in this release. · No professional clinical peer review is claimed. Recommended content is limited to accurately qualified research summaries.

study Family Id
NCT04813224
family Linkage Uncertain
false
approaches

emdr

id
dv-vision-42529059
aliases
None recorded
title
A pilot study of the feasibility and preliminary outcomes of sequential TF-CBT and EMDR online group therapy for adult women with histories of childhood sexual abuse.
journal
Frontiers in Psychology
neurotransmitters
None recorded
year
2026
authors
Milagros Molero-Zafra; María Jesús Hernández-Jiménez; Olga Fernández-García; Marián Pérez-Marín
design
Pilot randomized sequence study; completer analysis
kind
Journal article
identity Conflict
Not recorded
doi
10.3389/fpsyg.2026.1872104
pmid
42529059
urls

https://doi.org/10.3389/fpsyg.2026.1872104 · https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

collections

vision

categories

Clinical & self-report

targets
None recorded
priority
1
quotes
None recorded
summary
Most statistical tests were nonsignificant; descriptive gains among nine completers do not establish efficacy.
limitation
71% attrition, tiny sequence groups and no long-term follow-up; not independent replication of the 2024 report.
citation Count
Not recorded
citation Snapshot
count
Not recorded
source
Not recorded
retrieved At
Not recorded
status
not-assessed
study Design Assessment
category
rct
is Randomized Controlled Trial
true
basis
Full text reports randomized sequence assignment; same family as the 2024 trial.
sources

https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

review Scope
full-text
paper Trust Assessment
scope
Paper
status
assessed
score
2
randomized Controlled Trial
true
peer Reviewed
true
blinding
not-confirmed
basis
Full text reports randomized sequence assignment; same family as the 2024 trial.
sources

https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

review Scope
full-text
human Approval
false
display Crosses
2
masking Roles
participants
not established from accessed source
providers
not established from accessed source
assessors
Not blinded
analysts
not established from accessed source
rating Scale
library-trust-factor/1-3
citations By Collection
vision
Not recorded
topics
  1. key
    vision:domestic-family-violence
    title
    Domestic & Family Violence
    collection
    vision
    trust Score
    2
journal Key
frontiersinpsychology
journal Label
Frontiers in Psychology
chapter Entries
  1. id
    vision-dv-dv-vision-42529059
    aliases
    None recorded
    title
    A pilot study of the feasibility and preliminary outcomes of sequential TF-CBT and EMDR online group therapy for adult women with histories of childhood sexual abuse.
    authors
    Milagros Molero-Zafra; María Jesús Hernández-Jiménez; Olga Fernández-García; Marián Pérez-Marín
    year
    2026
    journal
    Frontiers in Psychology
    doi
    10.3389/fpsyg.2026.1872104
    pmid
    42529059
    urls

    https://doi.org/10.3389/fpsyg.2026.1872104 · https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

    collections

    vision

    categories

    Clinical & self-report

    targets
    None recorded
    neurotransmitters
    None recorded
    conditions
    None recorded
    condition Evidence
    None recorded
    age Groups

    adults

    age Population
    record Id
    dv-vision-42529059
    collections

    vision

    groups

    adults

    reported Ages
    Mean age 39.42 (SD10.23); observed range not established.
    youth Scope
    Not recorded
    youth Source Note
    Not recorded
    source URL
    https://pubmed.ncbi.nlm.nih.gov/42529059/
    basis Type
    source-limited-ai-editorial-assessment
    classification Note
    Original age terms: adults. Programme targets or possible eligibility are not counted as observed ages.
    community Matches
    1. category Id
      domestic-violence
      relation
      related
    kind
    Journal article
    design
    Pilot randomized sequence study; completer analysis
    origin
    approved-dv-20261101
    priority
    1
    quotes
    None recorded
    finding
    Most statistical tests were nonsignificant; descriptive gains among nine completers do not establish efficacy.
    summary
    Most statistical tests were nonsignificant; descriptive gains among nine completers do not establish efficacy.
    limitation
    71% attrition, tiny sequence groups and no long-term follow-up; not independent replication of the 2024 report.
    evidence
    evidence Type
    Pilot randomized sequence study; completer analysis
    intervention
    Sequential EMDR G-TEP and TF-CBT Sixteen sessions across two eight-week phases.
    comparator
    Reverse treatment sequence; no untreated control.
    sample
    9 of 31 eligible recruits completed both phases (5 EMDR→CBT, 4 CBT→EMDR).
    measurement
    Feasibility/retention; Symptoms and life satisfaction
    timing
    end of sixteen-week sequence; end of sequence
    trial Id
    NCT04813224
    relationship Note
    Related adult childhood-abuse evidence with explicit family-violence exposure in part of the cohort. Family violence is documented for part of the cohort, but not a whole-sample adult-IPV effect; no ongoing-violence outcome.
    measured Genes
    None recorded
    pathways
    None recorded
    source Access
    level
    full-text
    source URLs

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML

    retrieved At
    2026-10-30T07:22:28.727073+00:00
    outcomes
    1. name
      Feasibility/retention
      follow Up
      end of sixteen-week sequence
      result
      Nine of 31 completed the sequential protocol.
      effect Estimate
      29% retention
      uncertainty
      not established from accessed source
      primary Status
      feasibility focus
    2. name
      Symptoms and life satisfaction
      follow Up
      end of sequence
      result
      Descriptive changes; most statistical tests nonsignificant.
      effect Estimate
      not established from accessed source
      uncertainty
      not established from accessed source
      primary Status
      not established from accessed source
    quality
    risk Of Bias
    Exploratory completer-only analysis, high attrition, multiple comparisons.
    attrition
    9/31 completed both phases: 29% retention.
    confounding
    not established from accessed source
    adverse Findings
    No serious adverse events reported; evidence limited to this small retained sample.
    transfer Limits
    Adult clinical samples do not establish benefit for children or violence prevention.
    jadad
    not established
    masking Roles
    participants
    not established from accessed source
    providers
    not established from accessed source
    assessors
    Not blinded
    analysts
    not established from accessed source
    population
    relation
    related
    population
    Adult women with childhood sexual abuse
    exposure Evidence
    Full-text participant section describes CSA as frequently intrafamilial, with no exact whole-sample proportion; illustrative case involved intrafamilial CSA. Same NCT04813224 family as 2024.
    rationale
    Related adult childhood-abuse evidence with explicit family-violence exposure in part of the cohort.
    transfer Limit
    Family violence is documented for part of the cohort, but not a whole-sample adult-IPV effect; no ongoing-violence outcome.
    study Design Assessment
    category
    rct
    is Randomized Controlled Trial
    true
    basis
    Full text reports randomized sequence assignment; same family as the 2024 trial.
    sources

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

    review Scope
    full-text
    paper Trust Assessment
    scope
    Paper
    status
    assessed
    score
    2
    randomized Controlled Trial
    true
    peer Reviewed
    true
    blinding
    not-confirmed
    basis
    Full text reports randomized sequence assignment; same family as the 2024 trial.
    sources

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

    review Scope
    full-text
    human Approval
    false
    display Crosses
    2
    masking Roles
    participants
    not established from accessed source
    providers
    not established from accessed source
    assessors
    Not blinded
    analysts
    not established from accessed source
    rating Scale
    library-trust-factor/1-3
    jadad
    status
    unassessed
    score
    Not recorded
    citation Snapshot
    count
    Not recorded
    source
    Not recorded
    retrieved At
    Not recorded
    status
    not-assessed
    citation Count
    Not recorded
    publication Approval
    status
    approved-for-publication
    approved By
    Ben Korbel
    approved At
    2026-11-01
    assessment
    AI assessed; human approved for publication
    scope
    Qualified research-library summaries. No professional clinical peer review or treatment recommendation is claimed.
    source Revision
    audit-r2-4979b3c28950
    source Content Hash
    4979b3c28950d0de7d0b768204ad0d88cb284cfc41cba08f3f5c5b2c183caa1c
    source Access
    level
    full-text
    source URLs

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML

    retrieved At
    2026-10-30T07:22:28.727073+00:00
    study Family Id
    NCT04813224
    family Linkage Uncertain
    false
    approaches

    emdr

    record Id
    dv-vision-42529059
    source Pages
    None recorded
    editorial Audit
    auditor
    Codex (AI)
    completed At
    2026-10-31T05:11:05.655793+00:00
    prior Content Hash
    373a37ef943dc843ef68b101aa8bbbbe93cc399953d50ecb03023bbd3e540359
    prior Revision
    r1-373a37ef943d
    prior Source
    frozen-120
    source Verification
    id
    dv-vision-42529059
    doi
    10.3389/fpsyg.2026.1872104
    pmid
    42529059
    fresh Metadata
    Europe PMC core
    metadata Retrieved
    true
    metadata SHA256
    f57f9460d8b78aab429595ec73b0c944d01e041599d13bcf4874e6fccf840d63
    claim Check
    Headline finding/design/limitations compared with indexed abstract or accessible primary evidence; retained methods amendments separately adjudicated.
    sources

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

    applied Proposals
    None recorded
    method
    AI editorial assessment of all 130 publication records: compare identity, headline finding, design, relevance and limitations with indexed abstracts or available primary material; adjudicate retained source-supported methods amendments. This is a source-limited publication audit, not an independent full-text systematic review or a clinical guideline.
    limitations

    Abstract-only records do not establish allocation concealment, complete harms reporting or full risk of bias. · No formal independent RoB 2, GRADE appraisal or numerical reconstruction of every effect was performed. · Source-access labels describe retained appraisal evidence; fuller prior appraisals were checked through their source ledgers and selected material, not independently repeated in full. · Publication counts are not independent trial or participant counts; cohort links and overlapping review evidence remain provisional. · A randomized design cross does not indicate benefit, low risk of bias or human approval. No double-blind trial is verified in this release. · No professional clinical peer review is claimed. Recommended content is limited to accurately qualified research summaries.

    assessment Record
    id
    dv-vision-42529059
    title
    A pilot study of the feasibility and preliminary outcomes of sequential TF-CBT and EMDR online group therapy for adult women with histories of childhood sexual abuse.
    authors

    Milagros Molero-Zafra · María Jesús Hernández-Jiménez · Olga Fernández-García · Marián Pérez-Marín

    year
    2026
    journal
    Frontiers in Psychology
    doi
    10.3389/fpsyg.2026.1872104
    pmid
    42529059
    trial Registration

    NCT04813224

    collection
    vision
    intervention Family
    Clinical EMDR
    publication Type
    Secondary sequential-phase feasibility report
    study Family Id
    NCT04813224
    family Linkage Uncertain
    false
    existing Repository Matches
    None recorded
    relevance
    relation
    related
    population
    Adult women with childhood sexual abuse
    exposure Evidence
    Full-text participant section describes CSA as frequently intrafamilial, with no exact whole-sample proportion; illustrative case involved intrafamilial CSA. Same NCT04813224 family as 2024.
    rationale
    Related adult childhood-abuse evidence with explicit family-violence exposure in part of the cohort.
    transfer Limit
    Family violence is documented for part of the cohort, but not a whole-sample adult-IPV effect; no ongoing-violence outcome.
    age
    groups

    adults

    reported Range
    Mean age 39.42 (SD10.23); observed range not established.
    youth Scope
    Not recorded
    country
    Spain
    setting
    Online groups
    sample Size
    randomized
    Not recorded
    analyzed
    9
    description
    9 of 31 eligible recruits completed both phases (5 EMDR→CBT, 4 CBT→EMDR).
    intervention
    description
    Sequential EMDR G-TEP and TF-CBT
    dose
    Sixteen sessions across two eight-week phases.
    provider
    Clinical therapists
    comparator
    Reverse treatment sequence; no untreated control.
    outcomes
    1. name
      Feasibility/retention
      follow Up
      end of sixteen-week sequence
      result
      Nine of 31 completed the sequential protocol.
      effect Estimate
      29% retention
      uncertainty
      not established from accessed source
      primary Status
      feasibility focus
    2. name
      Symptoms and life satisfaction
      follow Up
      end of sequence
      result
      Descriptive changes; most statistical tests nonsignificant.
      effect Estimate
      not established from accessed source
      uncertainty
      not established from accessed source
      primary Status
      not established from accessed source
    finding
    Most statistical tests were nonsignificant; descriptive gains among nine completers do not establish efficacy.
    limitation
    71% attrition, tiny sequence groups and no long-term follow-up; not independent replication of the 2024 report.
    design
    type
    Pilot randomized sequence study; completer analysis
    randomization Evidence
    Full text reports randomized sequence assignment; same family as the 2024 trial.
    masking
    participants
    not established from accessed source
    providers
    not established from accessed source
    assessors
    Not blinded
    analysts
    not established from accessed source
    crosses
    1
    cross Rationale
    One cross for verified randomized sequence; high attrition does not justify double masking or a new trial count.
    quality
    risk Of Bias
    Exploratory completer-only analysis, high attrition, multiple comparisons.
    attrition
    9/31 completed both phases: 29% retention.
    confounding
    not established from accessed source
    adverse Findings
    No serious adverse events reported; evidence limited to this small retained sample.
    transfer Limits
    Adult clinical samples do not establish benefit for children or violence prevention.
    jadad
    not established
    access
    level
    full-text
    source URLs

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML

    retrieved At
    2026-10-30T07:22:28.727073+00:00
    sources
    1. url
      https://pubmed.ncbi.nlm.nih.gov/42529059/
      type
      bibliographic/primary abstract
      retrieved At
      2026-10-30T07:22:28.727073+00:00
      identity Verified
      true
      notes
      Title, DOI and authors reconciled across primary abstract or publisher-deposited metadata.
    2. url
      https://doi.org/10.3389/fpsyg.2026.1872104
      type
      bibliographic/primary abstract
      retrieved At
      2026-10-30T07:22:28.727073+00:00
      identity Verified
      true
      notes
      Title, DOI and authors reconciled across primary abstract or publisher-deposited metadata.
    3. url
      https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML
      type
      primary full text
      retrieved At
      2026-10-30T07:22:28.727073+00:00
      identity Verified
      true
      notes
      Source directly inspected for the extracted claims.
    4. url
      https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104
      type
      publisher-deposited Crossref status metadata
      retrieved At
      2026-10-30T07:26:45.630091+00:00
      identity Verified
      true
      notes
      Title/authors/DOI matched; update-to and relation fields checked.
    publication Status
    status
    published
    correction Retraction Check
    Crossref publisher-deposited update-to and relation fields were empty on 30 October 2026; no correction/retraction notice was identified in accessed metadata. This limited check cannot exclude unlinked notices. Europe PMC publication types and available correction/comment fields were also inspected; no retraction type or notice was present.
    uncertainty
    Publisher update links and future notices require checking before final approval.
    recommendation Rationale
    Retain as pending evidence for human review, with design and source-access limits visible.
    review
    status
    pending
    reviewer
    Not recorded
    assessment Status
    assessed
    assessment Notes

    Clinical EMDR evidence concerns a therapist-delivered multicomponent treatment; it does not isolate eye movements or validate standalone audiovisual content.

    research Lane
    vision
    review Ready
    true
    review Readiness
    ai-editorial-audit-complete-release-pending
    publication Recommendation
    status
    recommended-summary
    reason
    Suitable as a qualified research-library summary at the stated source-access level. This is not a conclusion that the intervention is effective or safe.
    scope
    Research summary only; no treatment recommendation
    human Release Approval
    false
    editorial Audit
    auditor
    Codex (AI)
    completed At
    2026-10-31T05:11:05.655793+00:00
    prior Content Hash
    373a37ef943dc843ef68b101aa8bbbbe93cc399953d50ecb03023bbd3e540359
    prior Revision
    r1-373a37ef943d
    prior Source
    frozen-120
    source Verification
    id
    dv-vision-42529059
    doi
    10.3389/fpsyg.2026.1872104
    pmid
    42529059
    fresh Metadata
    Europe PMC core
    metadata Retrieved
    true
    metadata SHA256
    f57f9460d8b78aab429595ec73b0c944d01e041599d13bcf4874e6fccf840d63
    claim Check
    Headline finding/design/limitations compared with indexed abstract or accessible primary evidence; retained methods amendments separately adjudicated.
    sources

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

    applied Proposals
    None recorded
    method
    AI editorial assessment of all 130 publication records: compare identity, headline finding, design, relevance and limitations with indexed abstracts or available primary material; adjudicate retained source-supported methods amendments. This is a source-limited publication audit, not an independent full-text systematic review or a clinical guideline.
    limitations

    Abstract-only records do not establish allocation concealment, complete harms reporting or full risk of bias. · No formal independent RoB 2, GRADE appraisal or numerical reconstruction of every effect was performed. · Source-access labels describe retained appraisal evidence; fuller prior appraisals were checked through their source ledgers and selected material, not independently repeated in full. · Publication counts are not independent trial or participant counts; cohort links and overlapping review evidence remain provisional. · A randomized design cross does not indicate benefit, low risk of bias or human approval. No double-blind trial is verified in this release. · No professional clinical peer review is claimed. Recommended content is limited to accurately qualified research summaries.

    study Design Assessment
    category
    rct
    is Randomized Controlled Trial
    true
    basis
    Full text reports randomized sequence assignment; same family as the 2024 trial.
    sources

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

    review Scope
    full-text
    paper Trust Assessment
    scope
    Paper
    status
    assessed
    score
    2
    randomized Controlled Trial
    true
    peer Reviewed
    true
    blinding
    not-confirmed
    basis
    One cross for verified randomized sequence; high attrition does not justify double masking or a new trial count.
    sources

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML · https://api.crossref.org/works/10.3389%2Ffpsyg.2026.1872104

    review Scope
    full-text
    human Approval
    false
    display Crosses
    1
    masking Roles
    participants
    not established from accessed source
    providers
    not established from accessed source
    assessors
    Not blinded
    analysts
    not established from accessed source
    jadad
    status
    unassessed
    score
    Not recorded
    evidence
    population
    relation
    related
    population
    Adult women with childhood sexual abuse
    exposure Evidence
    Full-text participant section describes CSA as frequently intrafamilial, with no exact whole-sample proportion; illustrative case involved intrafamilial CSA. Same NCT04813224 family as 2024.
    rationale
    Related adult childhood-abuse evidence with explicit family-violence exposure in part of the cohort.
    transfer Limit
    Family violence is documented for part of the cohort, but not a whole-sample adult-IPV effect; no ongoing-violence outcome.
    intervention
    description
    Sequential EMDR G-TEP and TF-CBT
    dose
    Sixteen sessions across two eight-week phases.
    provider
    Clinical therapists
    comparator
    Reverse treatment sequence; no untreated control.
    outcomes
    1. name
      Feasibility/retention
      follow Up
      end of sixteen-week sequence
      result
      Nine of 31 completed the sequential protocol.
      effect Estimate
      29% retention
      uncertainty
      not established from accessed source
      primary Status
      feasibility focus
    2. name
      Symptoms and life satisfaction
      follow Up
      end of sequence
      result
      Descriptive changes; most statistical tests nonsignificant.
      effect Estimate
      not established from accessed source
      uncertainty
      not established from accessed source
      primary Status
      not established from accessed source
    access
    level
    full-text
    source URLs

    https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML

    retrieved At
    2026-10-30T07:22:28.727073+00:00
    citation Snapshot
    count
    Not recorded
    source
    Not recorded
    retrieved At
    Not recorded
    status
    not-assessed
    provenance
    Discovered by AI
    content Hash
    4979b3c28950d0de7d0b768204ad0d88cb284cfc41cba08f3f5c5b2c183caa1c
    revision
    audit-r2-4979b3c28950
    archive Entries
    None recorded
    collection
    vision
    chapter Number
    7
    topic Id
    domestic-family-violence
    topic Title
    Domestic & Family Violence
    trust Score
    2
evidence
evidence Type
Pilot randomized sequence study; completer analysis
intervention
Sequential EMDR G-TEP and TF-CBT Sixteen sessions across two eight-week phases.
comparator
Reverse treatment sequence; no untreated control.
sample
9 of 31 eligible recruits completed both phases (5 EMDR→CBT, 4 CBT→EMDR).
measurement
Feasibility/retention; Symptoms and life satisfaction
timing
end of sixteen-week sequence; end of sequence
trial Id
NCT04813224
relationship Note
Related adult childhood-abuse evidence with explicit family-violence exposure in part of the cohort. Family violence is documented for part of the cohort, but not a whole-sample adult-IPV effect; no ongoing-violence outcome.
measured Genes
None recorded
pathways
None recorded
source Access
level
full-text
source URLs

https://pubmed.ncbi.nlm.nih.gov/42529059/ · https://doi.org/10.3389/fpsyg.2026.1872104 · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13416442/fullTextXML

retrieved At
2026-10-30T07:22:28.727073+00:00
outcomes
  1. name
    Feasibility/retention
    follow Up
    end of sixteen-week sequence
    result
    Nine of 31 completed the sequential protocol.
    effect Estimate
    29% retention
    uncertainty
    not established from accessed source
    primary Status
    feasibility focus
  2. name
    Symptoms and life satisfaction
    follow Up
    end of sequence
    result
    Descriptive changes; most statistical tests nonsignificant.
    effect Estimate
    not established from accessed source
    uncertainty
    not established from accessed source
    primary Status
    not established from accessed source
quality
risk Of Bias
Exploratory completer-only analysis, high attrition, multiple comparisons.
attrition
9/31 completed both phases: 29% retention.
confounding
not established from accessed source
adverse Findings
No serious adverse events reported; evidence limited to this small retained sample.
transfer Limits
Adult clinical samples do not establish benefit for children or violence prevention.
jadad
not established
masking Roles
participants
not established from accessed source
providers
not established from accessed source
assessors
Not blinded
analysts
not established from accessed source
population
relation
related
population
Adult women with childhood sexual abuse
exposure Evidence
Full-text participant section describes CSA as frequently intrafamilial, with no exact whole-sample proportion; illustrative case involved intrafamilial CSA. Same NCT04813224 family as 2024.
rationale
Related adult childhood-abuse evidence with explicit family-violence exposure in part of the cohort.
transfer Limit
Family violence is documented for part of the cohort, but not a whole-sample adult-IPV effect; no ongoing-violence outcome.
jadad
status
unassessed
score
Not recorded
condition Evidence
None recorded
conditions
None recorded
topic Trust Scores

2

full Text
status
not-indexed
retrieval Available
false

Open this publication in the interactive library